Scott Randal W., a director at BridgeBio Pharma, Inc. ($BBIO), sold shares on the open market five times over the last 365 days, totaling $1.42 million. His most recent sale occurred on February 17, 2026. These sales rank 4,166th among 11,678 insiders in our database, where the average is $8.6 million across 6.37 transactions. Scott Randal W. made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | M | Common Stock | 10000 | $16.75 | 25,589.0000 | 192,708,813 | 64.15% | 0.01% |
| Feb. 17, 2026 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | M | Stock Option (Right to Buy) | 10000 | $0.00 | 31,501.0000 | 192,708,813 | 24.10% | 0.01% |
| Feb. 17, 2026 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | S | Common Stock | 3307 | $75.93 | 15,589.0000 | 192,708,813 | 17.50% | 0.00% |
| Feb. 17, 2026 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | S | Common Stock | 4793 | $75.57 | 18,896.0000 | 192,708,813 | 20.23% | 0.00% |
| Feb. 17, 2026 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | S | Common Stock | 1900 | $74.34 | 23,689.0000 | 192,708,813 | 7.43% | 0.00% |
| Nov. 17, 2025 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | M | Stock Option (Right to Buy) | 10000 | $0.00 | 41,501.0000 | 192,708,813 | 19.42% | 0.01% |
| Nov. 17, 2025 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | M | Common Stock | 10000 | $16.75 | 25,589.0000 | 192,708,813 | 64.15% | 0.01% |
| Nov. 17, 2025 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | S | Common Stock | 3801 | $66.25 | 21,788.0000 | 192,708,813 | 14.85% | 0.00% |
| Nov. 17, 2025 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | S | Common Stock | 6199 | $66.89 | 15,589.0000 | 192,708,813 | 28.45% | 0.00% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Not found | A | Stock Option (Right to Buy) | 8425 | $0.00 | 8,425.0000 | 190,188,626 | 9999.99% | 0.00% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Not found | A | Common Stock | 6589 | $0.00 | 15,589.0000 | 190,188,626 | 73.21% | 0.00% |
| June 21, 2024 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Not found | A | Stock Option (Right to Buy) | 26014 | $0.00 | 26,014.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Not found | S | Common Stock | 1500 | $31.30 | 9,000.0000 | 0 | 14.29% | 0.00% |
| June 3, 2024 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Not found | S | Common Stock | 800 | $28.68 | 10,700.0000 | 0 | 6.96% | 0.00% |
| June 3, 2024 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Not found | S | Common Stock | 200 | $29.48 | 10,500.0000 | 0 | 1.87% | 0.00% |
| March 1, 2024 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Not found | S | Common Stock | 2500 | $34.00 | 11,500.0000 | 0 | 17.86% | 0.00% |
| Dec. 18, 2023 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | S | Common Stock | 2000 | $40.00 | 14,000.0000 | 0 | 12.50% | 0.00% |
| Dec. 1, 2023 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | S | Common Stock | 1500 | $30.00 | 16,000.0000 | 0 | 8.57% | 0.00% |
| Dec. 1, 2023 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | S | Common Stock | 1000 | $28.50 | 17,500.0000 | 0 | 5.41% | 0.00% |
| Sept. 5, 2023 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | S | Common Stock | 2500 | $30.00 | 18,500.0000 | 0 | 11.90% | 0.00% |
| June 21, 2023 | BridgeBio Pharma, Inc. | $BBIO | Scott Randal W. | Director | A | Stock Option (right to buy) | 51501 | $0.00 | 51,501.0000 | 0 | 9999.99% | 0.00% |